KEPIVANCE
NDC 66658-113, palifermin, injection, powder, lyophilized, for solution, from Swedish Orphan Biovitrum AB (publ).
- Product NDC
- 66658-113
- Status
- Listed
- Labeler
- Swedish Orphan Biovitrum AB (publ)
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125103
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66658-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALIFERMIN5.16 mg/1.2mL
Pharmacologic classes
Fibroblast Growth Factor 7 [CS]; Increased Epithelial Proliferation [PE]; Mucocutaneous Epithelial Cell Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66658-113-03 | 66658011303 | 3 VIAL, SINGLE-USE in 1 CARTON (66658-113-03) / 1.2 mL in 1 VIAL, SINGLE-USE (66658-113-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/426f6e64-2c20-4a61-6d65-7320426f6e64Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=66658-113
Use it
Look up 66658-113 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66658-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66658-113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.